Published in J Neurovirol on June 01, 2007
Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology (2009) 2.00
Medication and finance management among HIV-infected adults: the impact of age and cognition. J Clin Exp Neuropsychol (2010) 1.46
The semantic relatedness of cue-intention pairings influences event-based prospective memory failures in older adults with HIV infection. J Clin Exp Neuropsychol (2009) 1.37
HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol (2010) 1.31
Neurocognitive consequences of HIV infection in older adults: an evaluation of the "cortical" hypothesis. AIDS Behav (2011) 1.27
Relationship of ethnicity, age, education, and reading level to speed and executive function among HIV+ and HIV- women: the Women's Interagency HIV Study (WIHS) Neurocognitive Substudy. J Clin Exp Neuropsychol (2011) 1.20
Successful cognitive aging in persons living with HIV infection. J Neurovirol (2010) 1.11
Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study. Neurobiol Aging (2014) 1.05
Impact of HIV and aging on neuropsychological function. J Neurovirol (2012) 1.05
Longitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: impact of age and serostatus. J Neurovirol (2010) 1.04
Neurocognitive functioning in HIV-1 infection: effects of cerebrovascular risk factors and age. Clin Neuropsychol (2010) 1.02
Intraindividual variability in HIV infection: evidence for greater neurocognitive dispersion in older HIV seropositive adults. Neuropsychology (2011) 1.00
Update on HIV-associated neurocognitive disorders. Curr Neurol Neurosci Rep (2013) 0.99
Combined effects of aging and HIV infection on semantic verbal fluency: a view of the cortical hypothesis through the lens of clustering and switching. J Clin Exp Neuropsychol (2012) 0.94
Successful cognitive aging and health-related quality of life in younger and older adults infected with HIV. AIDS Behav (2014) 0.94
Aging, prospective memory, and health-related quality of life in HIV infection. AIDS Behav (2012) 0.93
Potential utility of resting-state magnetoencephalography as a biomarker of CNS abnormality in HIV disease. J Neurosci Methods (2012) 0.92
Verbal memory declines more rapidly with age in HIV infected versus uninfected adults. J Clin Exp Neuropsychol (2014) 0.86
Effect of HIV clade differences on the onset and severity of HIV-associated neurocognitive disorders. J Neurovirol (2013) 0.86
An examination of the age-prospective memory paradox in HIV-infected adults. J Clin Exp Neuropsychol (2011) 0.86
Physical Activity is Associated with Better Neurocognitive and Everyday Functioning Among Older Adults with HIV Disease. AIDS Behav (2015) 0.85
Older individuals with HIV infection have greater memory deficits than younger individuals. J Neurovirol (2013) 0.85
Cognitive reserve as a protective factor in older HIV-positive patients at risk for cognitive decline. Appl Neuropsychol Adult (2012) 0.85
Visuospatial and Attentional Abilities Predict Driving Simulator Performance Among Older HIV-infected Adults. Am J Alzheimers Dis Other Demen (2013) 0.84
The Montreal cognitive assessment to screen for cognitive impairment in HIV patients older than 60 years. J Acquir Immune Defic Syndr (2014) 0.83
Distal sensory polyneuropathy is associated with neuropsychological test performance among persons with HIV. J Int Neuropsychol Soc (2012) 0.81
Exploring Substance Use and HIV Treatment Factors Associated with Neurocognitive Impairment among People Living with HIV/AIDS. Front Public Health (2014) 0.81
Does Older Age Confer an Increased Risk of Incident Neurocognitive Disorders Among Persons Living with HIV Disease? Clin Neuropsychol (2015) 0.79
The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals. J Clin Exp Neuropsychol (2013) 0.78
Factors related to HIV-associated neurocognitive impairment differ with age. J Neurovirol (2014) 0.78
HIV/AIDS in older women: unique challenges, unmet needs. Behav Med (2014) 0.78
Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C. J Acquir Immune Defic Syndr (2016) 0.78
The Role of Extrinsic Rewards and Cue-Intention Association in Prospective Memory in Young Children. PLoS One (2015) 0.77
Prevention, Rehabilitation, and Mitigation Strategies of Cognitive Deficits in Aging with HIV: Implications for Practice and Research. ISRN Nurs (2013) 0.77
Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era. J Acquir Immune Defic Syndr (2016) 0.76
Shallow encoding and forgetting are associated with dependence in instrumental activities of daily living among older adults living with HIV infection. Arch Clin Neuropsychol (2014) 0.76
Intrinsic network connectivity abnormalities in HIV-infected individuals over age 60. J Neurovirol (2015) 0.75
Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning. J Clin Exp Neuropsychol (2017) 0.75
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet (2002) 5.60
The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS (2005) 4.48
HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol (2002) 4.20
Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection. PLoS One (2012) 3.69
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr (2012) 2.95
Stroke and encephalopathy after cardiac surgery: an update. Stroke (2005) 2.91
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure. J Infect Dis (2010) 2.45
A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment. Clin Infect Dis (2005) 2.25
Watershed strokes after cardiac surgery: diagnosis, etiology, and outcome. Stroke (2006) 1.98
An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol (2007) 1.94
Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects. J Infect Dis (2008) 1.91
Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s. J Infect Dis (2007) 1.89
Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy. Diabetes Care (2010) 1.86
Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol (2004) 1.79
Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--The Hawaii Aging with HIV Cohort. J Neurovirol (2006) 1.76
Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS). J Clin Exp Neuropsychol (2003) 1.70
Circulating proviral HIV DNA and HIV-associated dementia. AIDS (2005) 1.68
Evaluating sleep and cognition in HIV. J Acquir Immune Defic Syndr (2013) 1.64
Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV. Antivir Ther (2012) 1.64
Delirium after coronary artery bypass graft surgery and late mortality. Ann Neurol (2010) 1.63
Assessing HIV-associated dementia: modified HIV dementia scale versus the Grooved Pegboard. AIDS Read (2002) 1.56
Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095. Clin Infect Dis (2010) 1.53
Management of human immunodeficiency virus infection in advanced age. JAMA (2013) 1.51
A 72-week randomized study of the safety and efficacy of a stavudine to zidovudine switch at 24 weeks compared to zidovudine or tenofovir disoproxil fumarate when given with lamivudine and nevirapine. Antivir Ther (2012) 1.48
Length of red cell unit storage and risk for delirium after cardiac surgery. Anesth Analg (2014) 1.46
Intraoperative hemoglobin levels and transfusion independently predict stroke after cardiac operations. Ann Thorac Surg (2011) 1.45
Normative data for determining significance of test-retest differences on eight common neuropsychological instruments. Clin Neuropsychol (2004) 1.44
Greater than age-related changes in brain diffusion of HIV patients after 1 year. J Neuroimmune Pharmacol (2008) 1.44
Subjective memory symptoms in surgical and nonsurgical coronary artery patients: 6-year follow-up. Ann Thorac Surg (2009) 1.43
Cognitive function and neurodevelopmental outcomes in HIV-infected Children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study. Pediatr Infect Dis J (2013) 1.43
Diabetes, insulin resistance, and dementia among HIV-1-infected patients. J Acquir Immune Defic Syndr (2005) 1.35
Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging With HIV cohort. J Acquir Immune Defic Syndr (2006) 1.32
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer (2009) 1.28
HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients. PLoS One (2013) 1.27
Declined neural efficiency in cognitively stable human immunodeficiency virus patients. Ann Neurol (2009) 1.26
Cognitive performance related to HIV-1-infected monocytes. J Neuropsychiatry Clin Neurosci (2012) 1.26
The Effects of Age and HIV on Neuropsychological Performance. J Int Neuropsychol Soc (2010) 1.25
Change in brain magnetic resonance spectroscopy after treatment during acute HIV infection. PLoS One (2012) 1.25
Incidence and characterization of acute HIV-1 infection in a high-risk Thai population. J Acquir Immune Defic Syndr (2008) 1.24
Encephalopathy and stroke after coronary artery bypass grafting: incidence, consequences, and prediction. Arch Neurol (2002) 1.20
Impact of differential attrition on the association of education with cognitive change over 20 years of follow-up: the ARIC neurocognitive study. Am J Epidemiol (2014) 1.18
Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy. J Neurovirol (2008) 1.17
Mitochondrial DNA levels of peripheral blood mononuclear cells and subcutaneous adipose tissue from thigh, fat and abdomen of HIV-1 seropositive and negative individuals. Antivir Ther (2005) 1.16
HIV proviral DNA associated with decreased neuropsychological function. J Neuropsychiatry Clin Neurosci (2007) 1.16
Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA (2003) 1.14
Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study. Magn Reson Imaging (2010) 1.14
Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy. J Acquir Immune Defic Syndr (2003) 1.13
A high-affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: implications for treatment of HIV-1/AIDS. J Immunol (2009) 1.09
Amount of HIV DNA in peripheral blood mononuclear cells is proportional to the severity of HIV-1-associated neurocognitive disorders. J Neuropsychiatry Clin Neurosci (2009) 1.08
Depressive symptoms, quality of life, and neuropsychological performance in HIV/AIDS: the impact of gender and injection drug use. J Neurovirol (2005) 1.08
Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus-infected Thais from the 2NN Cohort Study. J Neurovirol (2010) 1.07
Normative data for 8 neuropsychological tests in older blacks and whites from the atherosclerosis risk in communities (ARIC) study. Alzheimer Dis Assoc Disord (2015) 1.06
Elevated blood pressure in HIV-infected individuals receiving highly active antiretroviral therapy. HIV Clin Trials (2003) 1.06
Impact of HIV and aging on neuropsychological function. J Neurovirol (2012) 1.05
HIV DNA and dementia in treatment-naïve HIV-1-infected individuals in Bangkok, Thailand. Int J Med Sci (2006) 1.04
Longitudinal psychomotor speed performance in human immunodeficiency virus-seropositive individuals: impact of age and serostatus. J Neurovirol (2010) 1.04
Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals. J Acquir Immune Defic Syndr (2012) 1.03
Regional cortical thinning associated with detectable levels of HIV DNA. Cereb Cortex (2011) 1.02
Distinct mechanisms of T cell reconstitution can be identified by estimating thymic volume in adult HIV-1 disease. J Infect Dis (2005) 1.00
A comparison of performance-based measures of function in HIV-associated neurocognitive disorders. J Neurovirol (2011) 0.99
Geriatric Syndromes in Older HIV-Infected Adults. J Acquir Immune Defic Syndr (2015) 0.99
Drug therapy persistence and stroke recurrence. Am J Manag Care (2006) 0.98
Antioxidant enzyme dysfunction in monocytes and CSF of Hispanic women with HIV-associated cognitive impairment. J Neuroimmunol (2008) 0.98
Peripheral blood HIV DNA is associated with atrophy of cerebellar and subcortical gray matter. Neurology (2013) 0.97
Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection. J Am Geriatr Soc (2014) 0.97
Deficits in self-awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV. AIDS Res Hum Retroviruses (2013) 0.96
Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s). J Acquir Immune Defic Syndr (2007) 0.95
HIV and recent illicit drug use interact to affect verbal memory in women. J Acquir Immune Defic Syndr (2013) 0.95
HIV-associated dementia, mitochondrial dysfunction, and oxidative stress. Mitochondrion (2004) 0.94
Small-vessel vascular disease in human immunodeficiency virus infection: the Hawaii aging with HIV cohort study. Cerebrovasc Dis (2007) 0.94
Characteristics of Activated Monocyte Phenotype Support R5-Tropic Human Immunodeficiency Virus. Immunol Immunogenet Insights (2009) 0.94
Cardiovagal autonomic function in HIV-infected patients with unsuppressed HIV viremia. HIV Clin Trials (2011) 0.94
Cortical atrophy and white matter hyperintensities in HIV: the Hawaii Aging with HIV Cohort Study. J Stroke Cerebrovasc Dis (2008) 0.94
Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090. HIV Clin Trials (2007) 0.94
Early postoperative cognitive dysfunction and blood pressure during coronary artery bypass graft operation. Arch Neurol (2007) 0.94
Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV. AIDS Care (2014) 0.93
A randomized trial of the impact of a programmable medication reminder device on quality of life in patients with AIDS. AIDS Patient Care STDS (2006) 0.93
Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease. Neurobiol Aging (2013) 0.93
Defining cognitive change after CABG: decline versus normal variability. Ann Thorac Surg (2006) 0.93
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report. Br J Haematol (2014) 0.92